Moth EB; Kiely BE; Martin A; Naganathan V; Della-Fiorentina S; Honeyball F; Zielinski R; Steer C; Mandaliya H; Ragunathan A, 2019, 'Older adults' preferred and perceived roles in decision-making about palliative chemotherapy, decision priorities and information preferences', Journal of Geriatric Oncology, http://dx.doi.org/10.1016/j.jgo.2019.07.026
Tervonen HE; Chen TYT; Lin E; Boyle FM; Moylan EJ; Della-Fiorentina SA; Beith J; Johnston A; Currow DC, 2019, 'Risk of emergency hospitalisation and survival outcomes following adjuvant chemotherapy for early breast cancer in New South Wales, Australia', European Journal of Cancer Care, vol. 28, http://dx.doi.org/10.1111/ecc.13125
Girgis A; Durcinoska I; Koh E-S; Ng W; Arnold A; Delaney GP; PROMPT-Care Pathways Working Group, 2018, 'Development of Health Pathways to Standardize Cancer Care Pathways Informed by Patient-Reported Outcomes and Clinical Practice Guidelines.', JCO Clin Cancer Inform, vol. 2, pp. 1 - 13, http://dx.doi.org/10.1200/CCI.18.00024
Chin-Lenn L; De Boer RH; Segelov E; Marx GM; Hughes TM; McCarthy NJ; White SC; Foo SS; Rutovitz JJ; Della-Fiorentina S, 2018, 'The impact and indications for Oncotype DX on adjuvant treatment recommendations when third-party funding is unavailable', Asia-Pacific Journal of Clinical Oncology, vol. 14, pp. 410 - 416, http://dx.doi.org/10.1111/ajco.13075
Girgis A; Durcinoska I; Gerges M; Kaadan N; Arnold A; Descallar J; Delaney GP; Avery S; Carolan M; Della-Fiorentina S, 2018, 'Study protocol for a controlled trial of an eHealth system utilising patient reported outcome measures for personalised treatment and care: PROMPT-Care 2.0', BMC Cancer, vol. 18, http://dx.doi.org/10.1186/s12885-018-4729-3
Colleoni M; Luo W; Karlsson P; Chirgwin J; Aebi S; Jerusalem G; Neven P; Hitre E; Graas MP; Simoncini E, 2018, 'Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial', The Lancet Oncology, vol. 19, pp. 127 - 138, http://dx.doi.org/10.1016/S1470-2045(17)30715-5
Ip E; Pokorny AMJ; Della-Fiorentina S; Beale P; Bray V; Kiely BE; Blinman P, 2017, 'Use of palliative chemotherapy in patients aged 80 years and over with incurable cancer: experience at three Sydney cancer centres', Internal Medicine Journal, vol. 47, pp. 75 - 81, http://dx.doi.org/10.1111/imj.13296
Zdenkowski N; Forbes JF; Boyle FM; Kannourakis G; Gill PG; Bayliss E; Saunders C; Della-Fiorentina S; Kling N; Campbell I, 2016, 'Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptorpositive breast cancer (ANZ0501 LATER): An open-label randomised, controlled trial', Annals of Oncology, vol. 27, pp. 806 - 812, http://dx.doi.org/10.1093/annonc/mdw055
Girgis A; Delaney GP; Arnold A; Miller AA; Levesque JV; Kaadan N; Carolan MG; Cook N; Masters K; Tran TT, 2016, 'Development and Feasibility Testing of PROMPT-Care, an eHealth System for Collection and Use of Patient-Reported Outcome Measures for Personalized Treatment and Care: A Study Protocol.', JMIR Res Protoc, vol. 5, pp. e227, http://dx.doi.org/10.2196/resprot.6459
Moth EB; Parry J; Stockler MR; Beale P; Blinman P; Della-Fiorentina S; Kiely BE, 2015, 'Doctor-to-doctor communication of prognosis in metastatic cancer: A review of letters from medical oncologists to referring doctors', Internal Medicine Journal, vol. 45, pp. 909 - 915, http://dx.doi.org/10.1111/imj.12776
Lakhanpal R; Yoong J; Joshi S; Yip D; Mileshkin L; Marx GM; Dunlop T; Hovey EJ; Della Fiorentina SA; Venkateswaran L, 2014, 'Geriatric assessment of older patients with cancer in Australia-A multicentre audit', Journal of Geriatric Oncology, http://dx.doi.org/10.1016/j.jgo.2015.03.001
Fox PN; Chatfield MD; Beith JM; Allison S; Della-Fiorentina S; Fisher D; Turley K; Grimison PS, 2013, 'Factors delaying chemotherapy for breast cancer in four urban and rural oncology units', ANZ Journal of Surgery, vol. 83, pp. 533 - 538, http://dx.doi.org/10.1111/j.1445-2197.2012.06254.x
Sandy J; Della-Fiorentina S, 2013, 'Relative dose intensity in early stage breast cancer chemotherapy: A retrospective analysis of incidence, risk factors and outcomes at a south-west Sydney cancer clinic', Asia-Pacific Journal of Clinical Oncology, vol. 9, pp. 365 - 372, http://dx.doi.org/10.1111/ajco.12093
Ramalingam S; Crawford J; Chang A; Manegold C; Perez-Soler R; Douillard JY; Thatcher N; Barlesi F; Owonikoko T; Wang Y, 2013, 'Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)', Annals of Oncology, vol. 24, pp. 2875 - 2880, http://dx.doi.org/10.1093/annonc/mdt371
Ng WL; Della-Fiorentina SA, 2010, 'The efficacy of oral ondansetron and dexamethasone for the prevention of acute chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy - a retrospective audit', European Journal of Cancer Care, vol. 19, pp. 403 - 407, http://dx.doi.org/10.1111/j.1365-2354.2009.01068.x
Al Bahrani BJ; Moylan EJ; Forouzesh B; Della-Fiorentina SA; Goldrick AJ, 2009, 'A short outpatient hydration schedule for cisplatin administration.', The gulf journal of oncology, pp. 30 - 36
Ellis PM; Delaney G; Della-Fiorentina S; Moylan E, 2004, 'Assessing outcomes of cancer care: Lessons to be learned from a retrospective review of the management of small cell lung cancer at the Cancer Therapy Centre, Liverpool Hospital, January 1996-July 200', Australasian Radiology, vol. 48, pp. 364 - 370, http://dx.doi.org/10.1111/j.0004-8461.2004.01320.x
Delaney G; Hui A; Berry M; Fowler A; Kneebone A; Barton M; Shakespeare T; Campbell G; Della-Fiorentina S; Brown K, 1999, 'Don't block the new kids', Australasian Radiology, vol. 43, pp. 562
Della-Fiorentina SA; Jaworski RC; Crandon AJ; Harnett PR, 1996, 'Primary peritoneal carcinoma: a treatable subset of patients with adenocarcinoma of unknown primary.', The Australian and New Zealand journal of surgery, vol. 66, pp. 124 - 125
